News

Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-‘1968, a GLP-1/GIP/Glucagon Receptor Triple Agonist

August 7, 2026 SDBN Comments Off

Initiation of study marks an important milestone in advancing Neurocrine’s obesity portfolio and investigational metabolic disease pipeline SAN DIEGO, Aug. 7, 2026 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of a […]

Maravai LifeSciences Reports Second Quarter 2026 Financial Results

August 6, 2026 SDBN Comments Off

SAN DIEGO–(BUSINESS WIRE)–Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the second quarter ended June 30, 2026, […]

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

August 6, 2026 SDBN Comments Off

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Q2 2026 Earnings Release Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks

News

QuidelOrtho Reports Second Quarter 2026 Financial Results

August 6, 2026 SDBN Comments Off

? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ? ? Excluding China, total revenue grew 6% both as reported and in constant currency ? […]

CALENDAR LISTING: DIII-D Public Tours Return by Popular Demand: Explore the Machine Unlocking the Power of the Sun

August 6, 2026 SDBN Comments Off

–(BUSINESS WIRE)–General Atomics: WHAT: San Diego will once again have a rare opportunity to step inside one of the nation’s leading fusion research facilities. After drawing strong public interest in the spring, General Atomics is […]

With ARPA-H Award, UC San Diego Engineers will Develop a Soft, Autonomous Robot for Stroke Care

August 6, 2026 SDBN Comments Off

A research team led by engineers at UC San Diego was awarded up to $26.1M from ARPA-H to develop a soft, flexible robot that can safely and autonomously navigate through the tiny blood vessels of […]

Could Spider-Man’s Web Ever Work in the Real World?

August 6, 2026 SDBN Comments Off

Spider silk is one of nature’s strongest and most remarkable materials. Inspired by the latest Spider-Man film, a materials scientist in the Jacobs School of Engineering explains why researchers are still trying to unlock its […]

Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results

August 6, 2026 SDBN Comments Off

SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant […]

Are the European Wildfires a Sign of a Climate Tipping Point?

August 6, 2026 SDBN Comments Off

Wildfires are burning across parts of Europe, including regions many people may not associate with severe fire risk. So what do these fires reveal? Judson Boomhower, associate professor of economics discusses how wildfire risk is […]

Rebecsinib Clinical Trial Means New Options for Blood Cancer

August 5, 2026 SDBN Comments Off

A clinical trial of rebecsinib — an investigational drug that inhibits the ADAR1 gene involved in the growth of more than 20 cancers — is underway at UC San Diego. Click here to view original […]

Nobel Laureate and UC San Diego Alumnus Susumu Tonegawa (1939-2026)

August 5, 2026 SDBN Comments Off

Susumu Tonegawa, who made key contributions to immunology and neurobiology and became UC San Diego’s first alumnus to receive a Nobel Prize, passed away on July 11. His research resolved a long-standing puzzle about how […]

Ourself’s Advanced Regenerative Serum Replaces and Outperforms a Three-Product Regimen, Landmark Split-Face Study Shows

August 5, 2026 SDBN Comments Off

In a split-face study, Ourself’s Advanced Regenerative Serum delivered greater improvement than a three-product stacked regimen across six of seven aesthetic parameters — while simplifying the routine to a single step and saving patients approximately […]

Blacksmith Medicines Announces Publication in Journal of Medicinal Chemistry Highlighting Discovery of a Non-Hydroxamate LpxC Inhibitor

August 5, 2026 SDBN Comments Off

SAN DIEGO, Aug. 5, 2026 /PRNewswire/ — Blacksmith Medicines, Inc. (Blacksmith), a leading biopharmaceutical company dedicated to discovering and developing therapeutics that target metalloenzymes, today announced the publication of research in the Journal of Medicinal […]

ImageneBio Reports Second Quarter 2026 Financial Results

August 5, 2026 SDBN Comments Off

SAN DIEGO, Aug. 05, 2026 (GLOBE NEWSWIRE) — ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today reported financial results for the quarter ended June 30, 2026, and provided a company update. Click here to […]

Mindfulness-Based Therapy for Opioid Misuse Offers Massive Return on Investment

August 5, 2026 SDBN Comments Off

A mindfulness-based treatment for opioid use disorder could generate $12 in economic benefit for every dollar spent, a massive improvement on current approaches. Click here to view original post Click Here to Publish/Feature Your Company […]

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026

August 5, 2026 SDBN Comments Off

SAN DIEGO, Aug. 5, 2026 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial […]

NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing

August 5, 2026 SDBN Comments Off

SAN DIEGO, Aug. 5, 2026 /PRNewswire/ — NueCell Bio, a newly established cell therapy science and development services company that utilizes proprietary modular translational development solutions focused on advancing modern cell therapies from scientific discovery […]

Acadia Pharmaceuticals Reports Second Quarter 2026 Financial Results

August 4, 2026 SDBN Comments Off

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced its financial results for the second quarter ended June 30, 2026. “Acadia delivered an outstanding second quarter, highlighted by strong commercial execution across both DAYBUE and […]

Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson’s Disease Data Readout Targeted for First Half of 2027

August 4, 2026 SDBN Comments Off

New BioSymetrics Inc. white paper and executed Master Collaboration Agreement establish an integrated roadmap spanning AI-driven patient stratification, human translational validation, biomarker development, and pharmaceutical partnering. SACRAMENTO, Calif., and SAN DIEGO, Calif., Aug. 4,… Click […]

One Month on a Vegan Diet Shifts Epigenetic Patterns Associated with Aging and Inflammation

August 4, 2026 SDBN Comments Off

Researchers from University of California San Diego have found that switching to a vegan diet for just one month can alter the body’s epigenetic landscape in ways associated with reduced inflammation and biological aging. Click […]

LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care

August 4, 2026 SDBN Comments Off

SAN DIEGO–(BUSINESS WIRE)–LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and […]

UC San Diego Students Learn Spatial Data Science Through Real-World Applications

August 4, 2026 SDBN Comments Off

UC San Diego students are bridging GIS and machine learning to solve real-world challenges in public health and urban planning. In a new spatial analysis course, they analyze complex geospatial data to identify environmental risks […]

BioSurplus Returns!

August 3, 2026 SDBN Comments Off

SAN DIEGO–(BUSINESS WIRE)–BioSurplus, one of the most recognized names in the life science equipment industry, has officially returned. For decades, BioSurplus helped organizations maximize the value of surplus laboratory assets while providing scientists and businesses […]

UC San Diego Launches New Business Data Science Major

August 3, 2026 SDBN Comments Off

The first program of its kind in the UC system, a new bachelor’s degree from the Hal?c?o?lu School for Data Science and Computing and the Rady School of Management will enable students to turn data […]

DLR Group Acquires Science and Technology Design Firm McFarlane Architects

August 3, 2026 SDBN Comments Off

SAN DIEGO–(BUSINESS WIRE)–Global integrated design firm DLR Group has acquired San Diego-based science and technology design firm McFarlane Architects. Click here to view original post Click Here to Publish/Feature Your Company or Product News with […]

ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results

August 3, 2026 SDBN Comments Off

SAN DIEGO, Aug. 03, 2026 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to […]

Inocras Closes $31 Million in Oversubscribed Series B-3 Financing to Accelerate U.S. Commercial Expansion

August 3, 2026 SDBN Comments Off

SAN DIEGO–(BUSINESS WIRE)–Inocras Closes $31 Million in Oversubscribed Series B-3 Financing to Accelerate U.S. Commercial Expansion. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Bloom Syndrome Association and NORD® Launch Natural History Study of Bloom Syndrome

July 31, 2026 SDBN Comments Off

Research study is open to participants worldwide to advance understanding of this ultra-rare cancer predisposition disorder and support future care guidelines, research, and treatment development SAN DIEGO, July 31, 2026 /PRNewswire/ — Today, the Bloom […]

L?kahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline

July 31, 2026 SDBN Comments Off

RUTHERFORD, N.J. & LA JOLLA, Calif.–(BUSINESS WIRE)–Glucotrack (NASDAQ: GCTK) today announced the continued expansion of the ai² Futures Lab™ operated through its wholly owned subsidiary, L?kahi Therapeutics™ Inc. During its first year, the ai² Futures […]

Quasar Medical Acquires Nitinol Design and Development Center

July 31, 2026 SDBN Comments Off

Acquisition Expands Quasar’s Technology Organization and Adds Nitinol Design, Development, and Manufacturing Capabilities SAN DIEGO, July 31, 2026 /PRNewswire/ — Quasar Medical, a global contract development and manufacturing organization (CDMO) specializing in minimally invasive medical… […]

Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-‘1968, a GLP-1/GIP/Glucagon Receptor Triple Agonist

Maravai LifeSciences Reports Second Quarter 2026 Financial Results

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

QuidelOrtho Reports Second Quarter 2026 Financial Results

CALENDAR LISTING: DIII-D Public Tours Return by Popular Demand: Explore the Machine Unlocking the Power of the Sun

With ARPA-H Award, UC San Diego Engineers will Develop a Soft, Autonomous Robot for Stroke Care

Could Spider-Man’s Web Ever Work in the Real World?

Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results

Are the European Wildfires a Sign of a Climate Tipping Point?

Rebecsinib Clinical Trial Means New Options for Blood Cancer

Nobel Laureate and UC San Diego Alumnus Susumu Tonegawa (1939-2026)

Ourself’s Advanced Regenerative Serum Replaces and Outperforms a Three-Product Regimen, Landmark Split-Face Study Shows

Blacksmith Medicines Announces Publication in Journal of Medicinal Chemistry Highlighting Discovery of a Non-Hydroxamate LpxC Inhibitor

ImageneBio Reports Second Quarter 2026 Financial Results

Mindfulness-Based Therapy for Opioid Misuse Offers Massive Return on Investment

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026

NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing

Acadia Pharmaceuticals Reports Second Quarter 2026 Financial Results

Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson’s Disease Data Readout Targeted for First Half of 2027

One Month on a Vegan Diet Shifts Epigenetic Patterns Associated with Aging and Inflammation

LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care

UC San Diego Students Learn Spatial Data Science Through Real-World Applications

BioSurplus Returns!

UC San Diego Launches New Business Data Science Major

DLR Group Acquires Science and Technology Design Firm McFarlane Architects

ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results

Inocras Closes $31 Million in Oversubscribed Series B-3 Financing to Accelerate U.S. Commercial Expansion

Bloom Syndrome Association and NORD® Launch Natural History Study of Bloom Syndrome

L?kahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline

Quasar Medical Acquires Nitinol Design and Development Center

Want to Save Time?

Get Weekly/Trending/Daily News & Jobs Delivered to Your Inbox